16
IRUS TotalDownloads
Altmetric
Inferring the epidemiological benefit of indoor vector control interventions against malaria from mosquito data
File | Description | Size | Format | ||
---|---|---|---|---|---|
s41467-022-30700-1.pdf | Published version | 911.53 kB | Adobe PDF | View/Open | |
ITN_IRS Entomological Evidence Nature Communications Supplementary Information All (in press).pdf | Supplementary information | 1.03 MB | Adobe PDF | View/Open | |
ITN_IRS Entomological Evidence Nature Communications Supplementary Data Legend.pdf | Supplementary information | 149.31 kB | Adobe PDF | View/Open | |
Supplementary_Data_1.xlsx | Supplementary information | 302.88 kB | Microsoft Excel XML | View/Open | |
Title: | Inferring the epidemiological benefit of indoor vector control interventions against malaria from mosquito data |
Authors: | Sherrard-Smith, E Ngufor, C Sanou, A Guelbeogo, M N’Guessan, R Elobolobo, E Saute, F Varela, K Chaccour, C Zulliger, R Wagman, J Robertson, ML Rowland, M Donnelly, M Gonahasa, S Staedke, S Kolaczinski, J Churcher, T |
Item Type: | Journal Article |
Abstract: | The cause of malaria transmission has been known for over a century but it is still unclear whether entomological measures are sufficiently reliable to inform policy decisions in human health. Decision-making on the effectiveness of new insecticide-treated nets (ITNs) and the indoor residual spraying of insecticide (IRS) have been based on epidemiological data, typically collected in cluster-randomised control trials. The number of these trials that can be conducted is limited. Here we use a systematic review to highlight that efficacy estimates of the same intervention may vary substantially between trials. Analyses indicate that mosquito data collected in experimental hut trials can be used to parameterize mechanistic models for Plasmodium falciparum malaria and reliably predict the epidemiological efficacy of quick-acting, neuro-acting ITNs and IRS. Results suggest that for certain types of ITNs and IRS using this framework instead of clinical endpoints could support policy and expedite the widespread use of novel technologies. |
Issue Date: | 5-Jul-2022 |
Date of Acceptance: | 17-May-2022 |
URI: | http://hdl.handle.net/10044/1/97565 |
DOI: | 10.1038/s41467-022-30700-1 |
ISSN: | 2041-1723 |
Publisher: | Nature Research |
Journal / Book Title: | Nature Communications |
Volume: | 13 |
Copyright Statement: | © The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/ licenses/by/4.0/. © The Author(s) 2022 |
Sponsor/Funder: | Medical Research Council (MRC) Bill & Melinda Gates Foundation |
Funder's Grant Number: | MR/R015600/1 n/a |
Keywords: | Animals Culicidae Humans Insecticide-Treated Bednets Insecticides Malaria Mosquito Control Mosquito Vectors Animals Humans Culicidae Malaria Insecticides Mosquito Control Insecticide-Treated Bednets Mosquito Vectors |
Publication Status: | Published |
Article Number: | ARTN 3862 |
Appears in Collections: | Faculty of Medicine School of Public Health |
This item is licensed under a Creative Commons License